Pharmaniaga Berhad (7081.KL)

MYR 0.36

(0.0%)

EBITDA Summary of Pharmaniaga Berhad

Pharmaniaga Berhad's latest annual EBITDA in 2023 was 7.34 Million MYR , up 96.7% from previous year.
Pharmaniaga Berhad's latest quarterly EBITDA in 2024 Q2 was 21.52 Million MYR , down -55.76% from previous quarter.
Pharmaniaga Berhad reported an annual EBITDA of -520.32 Million MYR in 2022, down -267.67% from previous year.
Pharmaniaga Berhad reported an annual EBITDA of 335.27 Million MYR in 2021, up 346.55% from previous year.
Pharmaniaga Berhad reported a quarterly EBITDA of 21.52 Million MYR for 2024 Q2, down -55.76% from previous quarter.
Pharmaniaga Berhad reported a quarterly EBITDA of 21.72 Million MYR for 2023 Q2, down -6.27% from previous quarter.

Annual EBITDA Chart of Pharmaniaga Berhad (2023 - 2019)

Historical Annual EBITDA of Pharmaniaga Berhad (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	7.34 Million MYR	96.7%
2022	-520.32 Million MYR	-267.67%
2021	335.27 Million MYR	346.55%
2020	94.43 Million MYR	-44.04%
2019	124.19 Million MYR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	56.42 Million MYR	405.97%
2024 Q2	21.52 Million MYR	-55.76%
2023 Q2	21.72 Million MYR	-6.27%
2023 Q4	-21.16 Million MYR	47.15%
2023 FY	- MYR	96.7%
2023 Q1	23.17 Million MYR	190.18%
2023 Q3	-40.05 Million MYR	-284.38%
2022 Q3	4.89 Million MYR	0.0%
2022 FY	- MYR	-267.67%
2022 Q4	-25.69 Million MYR	-624.68%
2021 FY	- MYR	346.55%
2020 FY	- MYR	-44.04%
2019 FY	- MYR	0.0%

Peer EBITDA Comparison of Pharmaniaga Berhad

Name	EBITDA	EBITDA Difference
Artroniq Berhad	-695 Thousand MYR	1157.266%
QES Group Berhad	33.26 Million MYR	77.91%
Optimax Holdings Berhad	28.58 Million MYR	74.294%
Apex Healthcare Berhad	441.93 Million MYR	98.337%